Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
2019 | |||
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study Journal:The Lancet Respiratory Medicine | 2019 |